The federal government has announced $48 million in Strategic Response Fund (SRF) contributions to Providence Health Care’s Clinical Support & Research Centre (CSRC), a cornerstone of the Jim Pattison Medical Campus in… Read More
Government investment will accelerate clinical development and strengthen Aspect’s advanced biomanufacturing capabilities for its bioengineered cellular medicines Vancouver, BC – Aspect Biosystems, a biotechnology company pioneering a novel category of… Read More
-With this expansion, any variant that results in production of CFTR protein is now included in the indication for ALYFTREK and TRIKAFTA, reinforcing the impact these medicines have, regardless of… Read More
KELOWNA, BC – Lexaria Bioscience Corp., a global innovator in drug delivery platforms is pleased to announce the engagement of the contract research organization (“CRO”) to execute and report on… Read More
RARITAN, N.J. — Johnson & Johnson announced the permanent Healthcare Common Procedure Coding System (HCPCS) J-code for INLEXZO™ (gemcitabine intravesical system) is now in effect. Adult patients living with certain types… Read More
